Abstract
A quantitative reverse transcriptase polymerase chain reaction (RT-PCR) method, employing internal standard (IS) RNA and a simplified chemiluminometric hybridization assay, is described for the determination of prostate-specific membrane antigen (PSMA) mRNA. The recombinant RNA IS has the same binding sites and size as the amplified PSMA mRNA. Biotinylated PCR products (263 bp) from PSMA mRNA and RNA IS are captured in microtiter wells coated with streptavidin, and hybridized with alkaline phosphatase-conjugated probes. The bound alkaline phosphatase (AP) is measured by using a chemiluminogenic substrate. The ratio of the luminescence values obtained for PSMA mRNA and the RNA IS is a linear function of the initial amount of PSMA mRNA present in the sample before RT-PCR. The linear range extends from 500 to 5,000,000 PSMA mRNA copies and the overall reproducibility of the assay, including RT-PCR and hybridization, ranges from 7.4 to 16.6%. Samples containing total RNA from PSMA-expressing LNCaP cells give luminescence ratios linearly related to the number of cells in the range 0.5–5,000 cells.
Similar content being viewed by others
References
Carter RE, Feldman AR, Coyle JT (1996) Proc Natl Acad Sci USA 93:749–753
Pinto JT, Suffoletto BP, Berzin TM, Qiao CH, Lin S, Tong WP, May F, Mukherjee B, Heston WD (1996) Clin Cancer Res 2:1445–1451
Israeli RS, Powell T, Fair WR, Heston WD (1993) Cancer Res 53:227–230
O’Keefe DS, Su SL, Bacich DJ, Horiguchi Y, Luo Y, Powell CT, Zandvliet D, Russell PJ, Molloy PL, Nowak NJ, Shows TB, Mullins C, Vonder Haar RA, Fair WR, Heston WD (1998) Biochim Biophys Acta 1443:113–127
Israeli RS, Powell T, Corr JG, Fair WR, Heston WDW (1994) Cancer Res 54:1807–1811
Lintula S, Stenman U-H (1997) J Urol 157:1969–1972
Kawakami M, Nakayama J (1997) Cancer Res 57:2321–2324
Burger MJ, Tebay MA, Keith PA, Samaratunga HM, Clements J, Lavin MF, Gardiner RA (2002) Int J Cancer 100:228–237
Stamey TA, Warrington JA, Caldwell MC, Chen Z, Fan Z, Mahadevappa M, McNeal JE, Nolley R, Zhang Z (2001) J Urol 166:2171–2177
Wright GL, Grob BM, Haley C, Grossman K, Newhall K, Petrylak D, Troyer J, Konchuba A, Schellhammer PF, Moriarty R (1996) Urology 48:326–334
Bostwick DG, Pacelli A, Blute M, Roche P, Murphy GP (1998) Cancer 82:2256–2261
Kahn D, Williams RD, Seldin DW, Libertino JA, Hirschhorn M, Dreicer R, Weiner GJ, Bushnell D, Gulfo J (1994) J Urol 152:1490–1495
Lu-Yao GL, McIerran D, Wasson J, Wennberg JE (1993) JAMA 269:2633–2655
Israeli RI, Miller WH, Su SL, Powell T, Fair WR, Samadi DS, Huryk RF, DeBlasio A, Edwards ET, Wise GJ, Heston WD (1994) Cancer Res 54:6306–6310
Lucotte G, Mercier G, Burckel A (1998) Mol Cell Probes 12:421–425
Renneberg H, Friedetzky A, Konrad L, Kurek R, Weingartner K, Wennemuth G, Tunn UW, Aumuller G (1999) Urol Res 27:23–27
Loric S, Dumas F, Eschwege P, Blanchet P, Benoit G, Jardin A, Lacour B (1995) Clin Chem 41:1698–1704
Cama C, Olsson CA, Raffo AJ, Perlman H, Buttyan R, O’Toole K, McMahon D, Benson MC, Katz AE (1995) J Urol 153:1373–1378
Llanes L, Ferruelo A, Paez A, Gomez JM, Moreno A, Berenguer A (2002) BJU Int 89:882–885
Adsan O, Cecchini MG, Bisoffi M, Wetterwald A, Klima I, Danuser H-I, Studer UE, Thalmann GN (2002) BJU Int 90:579–585
Hara N, Kasahara T, Kawasaki T, Bilim V, Obara K, Takahashi K, Tomita Y (2002) Clin Cancer Res 8:1794–1799
Grasso YZ, Gupta MK, Levin HS, Zippe CD, Klein EA (1998) Cancer Res 58:1456–1459
Gala J, Heusterspreute M, Loric S. Hanon F, Tombal B, Cangh PV, De Nayer P, Philippe M (1998) Clin Chem 44:472–481
Zhou L, Cryan EV, Minor LK, Gunnet JW, Demarest KT (2000) Anal Biochem 282:46–53
Czerwinski M, Opdam P, Madan A, Carroll K, Mudra DR, Gan LL, Luo G, Parkinson A (2002) Methods Enzymol 357:170–179
Acknowledgements
Financial support by a research grant (YPER) from the General Secretariat for Research and Technology (Greece) and Medicon Hellas SA is gratefully acknowledged.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Emmanouilidou, E., Ioannou, P.C. & Christopoulos, T.K. High-throughput chemiluminometric determination of prostate-specific membrane antigen mRNA in peripheral blood by RT-PCR using a synthetic RNA internal standard. Anal Bioanal Chem 380, 90–97 (2004). https://doi.org/10.1007/s00216-004-2719-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-004-2719-6